logo
Select company
Select metric
$ -12.08MEarning Before Interest & Taxes (EBIT)
VS
Market
29
Sector
61
Industry
75
History
-
$ 1.29Close
$ 0.73 - $ 1.49 52-Week Range
Ticker Information

Ticker

ESLA

Company Name

ESTRELLA IMMUNOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ESTRELLA IMMUNOPHARMA INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ESLA - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -12.08M
3/31/2025$ -10.48M
12/31/2024$ -8.85M
9/30/2024$ -8.82M
6/30/2024$ -7.31M
3/31/2024$ -6.09M
12/31/2023$ -8.36M
9/30/2023$ -7.41M
6/30/2023$ -11.11M
3/31/2023$ -818.06K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ESTRELLA IMMUNOPHARMA INC's latest trailing twelve months (TTM) EBIT stands at $ -247.72K.
  • Over the past 5 years, ESTRELLA IMMUNOPHARMA INC's average EBIT has been $ -5.64M.
  • The median EBIT for ESTRELLA IMMUNOPHARMA INC during this period was $ -7.31M
  • ESTRELLA IMMUNOPHARMA INC reached its highest EBIT over the past 5 years at $ -247.72K.
  • The lowest EBIT recorded by ESTRELLA IMMUNOPHARMA INC in the same timeframe $ -12.08M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

ESLA - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -12.08M

Minimum

Jun 30, 2025

$ -247.72K

Maximum

Dec 31, 2021

$ -5.64M

Average

$ -7.31M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.81M with a standard deviation of $ 130.86M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 443M
average$ 28.81M
median$ 1.05M
std$ 130.86M